A research team led by Václav Vopálenský and Martin Pospíšek from the Faculty of Science, Charles University, has discovered ...

The safety of mRNA vaccines, hailed as a saviour in the covid-19 pandemic, has been called into question by the US ...

The company submitted an application for a seasonal flu vaccine it believes to be a key growth driver in the years ahead.

Researchers at Penn Medicine have developed an mRNA vaccine that could potentially cure allergies by stopping allergens from ...

In a recent study posted to the bioRxiv* preprint server, researchers described a messenger ribonucleic acid (mRNA)-lipid nanoparticle mpox vaccine encoding four conserved mpox virus surface proteins ...

In a recent study posted to the bioRxiv* preprint server, researchers in China demonstrated the efficacy of three messenger ribonucleic acid (mRNA) technology-based Monkeypox virus (MPXV) vaccines in ...

Please provide your email address to receive an email when new articles are posted on . There are now three FDA approved RSV vaccines. This marks the first mRNA vaccine approved by the FDA for the ...

Moderna, Inc. MRNA announced that it has started dosing healthy participants in a phase I study, which is evaluating the safety, tolerability and immunogenicity of its mRNA-based vaccine candidate, ...

Foundation-funded project targets infectious bronchitis and infectious laryngotracheitis viruses.

A virus relies on the host's translation machinery to replicate itself and become infectious. Translation efficiency ...